Literature DB >> 19223126

The failure of HIV vaccines: a new autovaccine may overcome some problems.

Velio Bocci1, Valter Travagli, Iacopo Zanardi.   

Abstract

The hypothesis of an autovaccine for HIV is borne out by: (1) the present lack of a valid vaccine; (2) by a remarkable improvement of the HAART, which however does not prevent HIV mutagenicity and a consequent valid immunological response and (3) the persistence of a hidden infection ready to thrive again. The preparation of the autovaccine is described as well as the administration schedule but only a clinical study will define its validity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19223126     DOI: 10.1016/j.mehy.2008.12.034

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  3 in total

Review 1.  Potential Cytoprotective Activity of Ozone Therapy in SARS-CoV-2/COVID-19.

Authors:  Gregorio Martínez-Sánchez; Adriana Schwartz; Vincenzo Di Donna
Journal:  Antioxidants (Basel)       Date:  2020-05-06

Review 2.  A Review on SARS-CoV-2-Induced Neuroinflammation, Neurodevelopmental Complications, and Recent Updates on the Vaccine Development.

Authors:  Medha Karnik; Narasimha M Beeraka; Chinnappa A Uthaiah; Suma M Nataraj; Anjali Devi S Bettadapura; Gjumrakch Aliev; SubbaRao V Madhunapantula
Journal:  Mol Neurobiol       Date:  2021-06-05       Impact factor: 5.590

3.  A pilot study for treatment of COVID-19 patients in moderate stage using intravenous administration of ozonized saline as an adjuvant treatment-registered clinical trial.

Authors:  Alok Sharma; Mili Shah; Satya Lakshmi; Hemangi Sane; Jignasha Captain; Nandini Gokulchandran; Pallavi Khubchandani; M K Pradeep; Prakash Gote; Balaji Tuppekar; Pooja Kulkarni; Amruta Paranjape; Radhika Pradhan; Ritu Varghese; Sushil Kasekar; Vivek Nair; Ummeammara Khanbande
Journal:  Int Immunopharmacol       Date:  2021-04-30       Impact factor: 5.714

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.